Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Limb Ischemic Preconditioning Reduces Heart and Lung Injury After an Open Heart Operation in Infants
Pediatric Cardiology, 10/06/09
Wenwu Z et al. – Limb RIPC can be applied safely and easily in infants, can attenuate systemic inflammatory response syndrome, and can increase systemic tolerance to IRI, imparting a protective effect against myocardial and pulmonary IRI. The expression of HSP 70 has an important role in the mechanism of action for RIPC.
Related Articles
Anomalous Origin of a Coronary Artery from the Right Branchiocephalic Trunk Associated with Complex Congenital Heart Disease
Pediatric Cardiology, 11/02/09
Relevance Score: 81%
Melody Transcatheter Valve Demonstrates Encouraging Results in Study on Patients with Congenital Heart Disease
Medtronic, 10/28/09
Relevance Score: 81%
Three-dimensional cine MRI in free-breathing infants and children with congenital heart disease
Pediatric Radiology, 10/19/09
Relevance Score: 81%
Atrial Arrhythmias in Adults With Congenital Heart Disease
Circulation, 10/14/09
Relevance Score: 81%
Left Ventricle to Right Ventricle Size Discrepancy in the Fetus: The Presence of Critical Congenital Heart Disease Can Be Reliably Predicted
Journal of the American Society of Echocardiography, 10/14/09
Relevance Score: 80%
Today in Pediatric Pulmonology...keeping you current
Receive free subspecialty "5-minute updates" via email
Development and Implementation of a National Programme for the Management of Severe and Very Severe Pneumonia in Children in Malawi
PLoS Medicine, 12/02/09
Comparison of Ultrasound and CT in the Evaluation of Pneumonia Complicated by Parapneumonic Effusion in Children
American Journal of Roentgenology, 12/02/09
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


